Caribbean Nutraceuticals, Inc.
FEI 3003856310 · United States
Per FDA, as of 2026-10-31 · Sources: FDA Data Dashboard, Import Alerts, Enforcement Reports
Get a dated evidence report for this supplierFree · for your supplier file · sample
Import alerts
0
Import refusals (5 years)
0
Warning letters
0
Last FDA action
2004-03-18
22 years ago
FDA record
- 2004-03-18RecallRecall F-118-5 · Class 2 · The product is adulterated since it contains the new dietary ingredient, androstenedione, for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable riskof illness or injury.Dietary supplement labeled in part: ''***NATURE***Sex.Plex for him***Directions: As an adult supplement, for nutritional support***Manufactured by CARIBBEAN NUTRACEUTICAL, INC. Las Piedras, PR 00771***Distributed by Nutrinet Concept, Corp. …Source: FDA Enforcement Reports
- 2004-03-18RecallRecall F-119-5 · Class 2 · The product is adulterated since it contains the new dietary ingredient, androstenedione, for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable riskof illness or injury.Dietary supplement labeled in part: ''***Nature***Sex.Plex for her***Directions: As an adult supplement, for nutritional support***Manufactured by CARIBBEAN NUTRACEUTICAL, INC. Las Piedras, PR 00771***Distributed by Nutrinet Concept, Corp. …Source: FDA Enforcement Reports
- 2004-03-18RecallRecall F-120-5 · Class 2 · The product is adulterated since it contains the new dietary ingredient, androstenedione, for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable riskof illness or injury.Dietary supplement labeled in part: ''***Viga*** Supplements Facts***Serving Size 1 Tablet***Saw Palmetto Extract 20mg* Androstenedione 10mg*Tribulus Terrestris Extract***Lot 04010010 Exp 01/07*** 30 Tabletas*** Manufactured for Nutrient Co…Source: FDA Enforcement Reports